🇺🇸 FDA

Company profile · Sponsor

Kunming

Kunming Hope of Health Hospital

C55DEA9 · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Kunming (C55DEA9) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C55DEA9
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. Experimental: Venetoclax in combination with Decitabine (+-sorafenib)

    Kunming

    Elderly AML Patients

    phase 3 other active

    1 trial

  2. Recombinant adeno-associated virus administration

    Kunming

    Menkes Syndrome

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

What is Kunming?

Kunming (C55DEA9) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Kunming sponsor?

We track 2 ClinicalTrials.gov-linked programs for Kunming, including Experimental: Venetoclax in combination with Decitabine (+-sorafenib) and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Kunming company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.